DEARBORN PARTNERS LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEARBORN PARTNERS LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2015$490,000
-30.2%
69,590
-23.6%
0.04%
-32.8%
Q4 2014$702,000
+110.2%
91,089
+103.5%
0.06%
+100.0%
Q3 2014$334,000
-2.6%
44,767
+26.4%
0.03%
-5.9%
Q2 2014$343,000
+1.8%
35,407
-12.6%
0.03%
-8.1%
Q1 2014$337,000
+17.8%
40,502
+19.7%
0.04%
+12.1%
Q4 2013$286,000
-41.3%
33,848
-44.6%
0.03%
-48.4%
Q3 2013$487,000
+3.4%
61,0640.0%0.06%
-4.5%
Q2 2013$471,00061,0640.07%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders